Skip to main content
SpringerLink
Log in

Pulmonary Emphysema: What’s Going On

  • Chapter
Biochemistry of Pulmonary Emphysema

Part of the book series: Current Topics in Rehabilitation ((CURRENT REHAB))

  • 296 Accesses

Abstract

Pulmonary emphysema and chronic bronchitis, usually defined by the mutual term “Chronic Obstructive Pulmonary Disease” (COPD), are clinical conditions characterized by disabling airflow limitation, productive cough, and dyspnoea. Cigarette smoking is the major risk factor associated with the development of these chronic disorders, and has assumed alarming proportions during the past fifty years. A few figures convey the magnitude of the problem: in the USA, COPD was responsible in 1987 for 354,000 hospitalizations and 74,000 deaths.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Snider G.L., Kleinerman J., Thurlbeck W.M., Bengali Z.H.: The definition of emphysema. Report of a National Heart, Lung, and Blood Institute, Division of Lung Diseases Workshop. Am. Rev. Respir. Dis. 1985; 132: 182–185

    Google Scholar 

  2. Marshall G., Perry K.M.A.: Diseases of the Chest. London: Butterworth Co., 1952

    Google Scholar 

  3. Laurell C.B., Eriksson S.: The electrophoretic alphal-globulin pattern of serum in al-antitrypsin deficiency. Scand. J. Clin. Lab. Invest. 1963; 15: 132–140

    CAS  Google Scholar 

  4. Gross P., Babjak M.A., Tolker E., Kaschak M.: Enzymatically produced pulmonary emphysema; a preliminary report. J. Occup. Med. 1964; 6: 481–484

    PubMed  CAS  Google Scholar 

  5. Travis J., Salvesen G.: Human plasma proteinase inhibitors. Ann. Rev. Biochem. 1983; 52: 655–709

    Article  PubMed  CAS  Google Scholar 

  6. Hutchinson D.C.S.: Epidemiology of a-1-protease inhibitor deficiency. Eur. Respir. J. 1990; 3 (suppl. 9): 29s - 34s

    Google Scholar 

  7. Gadek J.E., Fells G.A., Zimmerman R.C., Rennard S.I., Crystal R.G.: Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema. J. Clin. Invest. 1981; 68: 889–898

    Article  PubMed  CAS  Google Scholar 

  8. Silverman E.K., Pierce J.A., Province M.A., Pao D.C., Campbell E.J.: Variability of pulmonary function in al-antitrypsin deficiency: clinical correlates. Ann. Intern. Med. 1989; 111: 982–991

    Article  PubMed  CAS  Google Scholar 

  9. Janoff A.: Elastases and emphysema. Current assessment of the protease-antiprotease hypothesis. Am. Rev. Respir. Dis. 1985; 132: 417–433

    PubMed  CAS  Google Scholar 

  10. Beatty K., Bieth J., Travis J.: Kinetics of association of serine proteinases with native and oxidized a-1 -proteinase inhibitor and alphal-antichymotrypsin. J. Biol. Chem. 1980; 225: 3931–3934

    Google Scholar 

  11. Pryor W.A., Dooley M.M., Church D.F.: Inactivation of human plasma al -proteinase inhibitor by gas phase cigarette smoke. Biochem. Biophys. Res. Commun. 1984; 122: 676–681

    Article  PubMed  CAS  Google Scholar 

  12. Hunninghake G.W., Crystal R.G.: Cigarette smoking and lung destruction: accumulation of neutrophils in the lungs of cigarette smokers. Am. Rev. Respir. Dis. 1983; 128: 833–838

    PubMed  CAS  Google Scholar 

  13. MacNee W., Wiggs B., Belzberg A.S., Hogg J.C.: The effect of cigarette smoking on neutrophil kinetics in human lungs. N. Engl. J. Med. 1989; 321: 924–928

    Article  PubMed  CAS  Google Scholar 

  14. Janoff A.: Biochemical links between cigarette smoking and pulmonary emphysema. J. Appl. Physiol. 1983; 55: 285–293

    PubMed  CAS  Google Scholar 

  15. Kimmel E.C., Winsett D.W., Diamond L.: Augmentation of elastase-induced emphysema by cigarette smoking. Description of a model and a review of possible mechanisms. Am. Rev. Respir. Dis. 1985; 132: 885–893

    PubMed  CAS  Google Scholar 

  16. Travis J.: a-1-proteinase inhibitor deficiency. In Massaro D. (Ed) Lung Cell Biology. New York, Marcel Dekker, Inc., 1989, pp 1227–1246

    Google Scholar 

  17. Gast A., Dietmann-Molard A., Pelletier A., Pauli G., Bieth J.G.: The antielastase screen of the lower respiratory tract of a—1 -proteinase inhibitor-sufficient patients with emphysema or pneumothorax. Am. Rev. Respir. Dis. 1990; 141: 880–883

    Article  PubMed  CAS  Google Scholar 

  18. Wewers M.D., Herzyk D.J., Gadek J.E.: Comparison of smoker and nonsmoker lavage fluid for the rate of association with neutrophil elastase. Am. J. Respir. Cell Mol. Biol. 1989; 1: 423–429

    Article  PubMed  CAS  Google Scholar 

  19. Stockley R.A.: a—l-antitrypsin and the pathogenesis of emphysema. Lung 1987; 165:61–77

    Google Scholar 

  20. Afford S.C., Burnett D., Campbell E.J., Cury J.D., Stockley R.A.: The assessment of a-1proteinase inhibitor form and function in lung lavage fluid from healthy subjects. Biol. Chem. Hoppe-Seyler 1988; 369: 1065–1074

    Article  PubMed  CAS  Google Scholar 

  21. Poller W., Meisen C., Olek K.: DNA polymorphisms of the al -antitrypsin gene region in patients with chronic obstructive pulmonary disease. Eur. J. Clin. Invest. 1990; 20: 1–7

    PubMed  CAS  Google Scholar 

  22. Gasparini P., Savoia A., Luisetti M., Peona V., Pignatti P.F.: The cystic fibrosis gene is not likely to be involved in chronic obstructive pulmonary disease. Am. J. Respir. Cell Mol. Biol. 1990; 2: 297–299

    Article  PubMed  CAS  Google Scholar 

  23. Wanner A., Sackner M.A.: Pulmonary Diseases. Mechanisms of altered structure and function. Boston/Toronto, Little, Brown and Co., 1983

    Google Scholar 

  24. Campbell E.J.: Preventive therapy of emphysema. Lessons from the elastase model. Am. Rev. Respir. Dis. 1986; 134: 435–437

    PubMed  CAS  Google Scholar 

  25. Pierce J.A.: Antitrypsin and emphysema. Perspective and prospects. JAMA 1988; 259: 2890–2895

    Article  PubMed  CAS  Google Scholar 

  26. Pozzi E., De Rose V., Luisetti M.: Strategies in the pharmacologic prevention of lung emphysema. In Olivieri D., Bianco S. (Eds) Airway obstruction and inflammation. Prog. Resp. Res., Basel, Karger, 1990, vol. 24, pp 203–208

    Google Scholar 

  27. Hubbard R.C., Crystal R.G.: Augmentation therapy of alphal-antitrypsin deficiency. Eur. Respir. J. 1990; 3 (Suppl. 9): 44s - 52s

    Google Scholar 

  28. American Thoracic Society: Guidelines for the approach to the patient with severe hereditary a1-antitrypsin deficiency. Am. Rev. Respir. Dis. 1989; 140: 1494–1497

    Article  Google Scholar 

  29. Hubbard R.C., Brantly M.L., Sellers S.E., Mitchell M.E., Crystal R.G.: Anti-neutrophil elastase defenses of the lower respiratory tract in al-antitrypsin deficiency directly augmented with an aerosol of al-antitrypsin. Ann. Intern. Med. 1989; 111: 206–212

    Article  PubMed  CAS  Google Scholar 

  30. Courtney M., Buchwalder A., Tessier L.H., Joye M., Benavente A., Balland A., Kohli V., Luthe R., Tolstoshev P., Lecocq J.P.: High-level production of biologically active human a-1-antitrypsin in Escherichia Coli. Proc. Natl. Acad. Sci. USA 1984; 81: 669–673

    Article  PubMed  CAS  Google Scholar 

  31. Travis J., Owen M., George P., Carrell R., Rosemberg S., Hallewell R.A., Barr P.J.: Isolation and properties of recombinant DNA produced variants of human a-1-proteinase inhibitor. J. Biol. Chem. 1985; 260: 4384–4389

    PubMed  CAS  Google Scholar 

  32. Jallot S., Carvallo D., Tessier L.H., Roecklin D., Roitsch C., Ogushi F., Crystal R.G., Courtney M.: Altered specificities of genetically engineered a—l-antitrypsin variants. Protein Eng. 1986; 1: 29–35

    Article  Google Scholar 

  33. Garver R.I., Chytil A., Karlsson S., Fells G.A., Brantly M.C., Courtney M., Kantoff P.W., Nienhais A.W., Anderson W.F., Crystal R.G.: Production of glycosylated physiologically “normal” human a-1-antitrypsin by mouse fibroblasts modified by insertion of a human a-1antitrypsin cDNA using a retroviral vector. Proc. Natl. Acad. Sci. USA 1987; 84: 1050–1054

    Article  PubMed  CAS  Google Scholar 

  34. Garver R.I., Chytil A., Courtney M., Crystal R.G.: Clonal gene therapy: transplanted mouse fibroblast clones express human a-1-antitrypsin gene in vivo. Science 1987; 237: 762–764

    Article  PubMed  CAS  Google Scholar 

  35. Perlemutter D.H., Pierce J.A.: The a-1-antitrypsin gene and emphysema. Am. J. Physiol. (Lung Cell Mol. Physiol.) 1989; 257: L147 - L162

    Google Scholar 

  36. Sifers R.N., Hordick C.P., Woo S.L.C.: Disruption of the 290–342 salt bridge is not responsible for the secretory defect of the PiZ a—l-antitrypsin variant. J. Biol. Chem. 1989; 264: 2997–3001

    PubMed  CAS  Google Scholar 

  37. Brantly M., Courtney M., Crystal R.G.: Repair of the secretion defect in the Z form of the a-1antitrypsin by addition of a second mutation. Science 1988; 242: 1700–1702

    Article  PubMed  CAS  Google Scholar 

  38. Bruch M., Bieth J.G: Influence of elastin on the inhibition of leucocyte elastase by a—1 -proteinase inhibitor and bronchial inhibitor. Potent inhibition of elastin-bound elastase by bronchial inhibitor. Biochem. J. 1986; 238: 269–273

    PubMed  CAS  Google Scholar 

  39. Kramps J.A., Te Boekhorst A.H.T., FransenJ.A.M., Ginsel L.A., Dijkman J H Antileukoprotease is associated with elastin fibers in the extracellular matrix of the human lung. An immunoelectron microscopic study. Am. Rev. Respir. Dis. 1989; 140: 471–476

    CAS  Google Scholar 

  40. Powers J.C., Bengali Z.H.: Elastase inhibitors for treatment of emphysema. Approaches to synthesis and biological evaluation. Am. Rev. Respir. Dis. 1986; 134: 1097–1100

    PubMed  CAS  Google Scholar 

  41. Luisetti M., Piccioni P.D., Donnini M, Peona V., Pozzi E., Grassi C.: Studies of MR 889, a new synthetic proteinase inhibitor. Biochem. Biophys. Res. Commun. 1989; 165: 568–573

    Article  PubMed  CAS  Google Scholar 

  42. Baici A., Pelloso R., Horler D.: The kinetic mechanism of inhibition of human leukocyte elastase by MR 889, a new cyclic thiolic compound. Biochem. Pharmacol. 1990; 39: 919–924

    Article  PubMed  CAS  Google Scholar 

  43. Doherty J.B., Ashe B.M., Argenhight L.W., Barker P.L., Bormey R.J., Chandler G.O., Dahlgren M.E., Dorn Jr C.P., Finke P.E., Firestone P.A., Fletcher D., Hagmann W.K., Mumford R., O’Grady L., Maycock A.C., Pisano J.M., Shah S.K., Thompson K.R., Zimmerman M.: Cephalosporin antibiotics can be modified to inhibit human leukocyte elastase. Nature 1986; 322: 192–194

    Article  PubMed  CAS  Google Scholar 

  44. Snider G.L., Stone P. J., Lucey E.C.: The specific treatment of emphysema. Eur. Respir. J. 1990; 3 (Suppl.9): 23s - 28s

    Google Scholar 

  45. Cohen A.B.: Treatment of the underlying cause of emphysema. Sem. Respir. Med. 1986; 8: 177–183

    Article  Google Scholar 

  46. Stevens M.D., Miller E.J., Cohen A.B.: Search for drugs that may reduce the load of neutrophil azurophilic granule enzymes in the lungs of patients with emphysema. Exp. Lung Res. 1989; 15: 663–680

    Article  PubMed  CAS  Google Scholar 

  47. Heffner J.E., Repine J.E.: Pulmonary strategies of antioxidant defense. Am. Rev. Respir. Dis. 1989; 140: 531–554

    Article  PubMed  CAS  Google Scholar 

  48. Hubbard R.C., Crystal R.G.: Antiproteases and antioxidants: strategies for the pharmacologic prevention of lung destruction. Respiration 1986; 50 (Supp1.l): 56–73

    Article  PubMed  CAS  Google Scholar 

  49. Cantin A.M., North S.L., Hubbard R.C., Crystal R.G.: Normal alveolar epithelial lining fluid contains high levels of glutathione. J. Appl. Physiol. 1987; 63: 152–157

    PubMed  CAS  Google Scholar 

  50. Taylor J.C., Madison R., Kosinska D.: Is antioxidant deficiency related to chronic obstructive pulmonary disease ? Am. Rev. Respir. Dis. 1986; 134: 285–289

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Phthisiology and Respiratory Diseases, IRCCS San Matteo, University of Pavia, Italy

    C. Grassi & M. Luisetti

Authors
  1. C. Grassi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Luisetti
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institute of Phthisiology and Respiratory Diseases, IRCCS San Matteo, University of Pavia, Italy

    C. Grassi  & M. Luisetti  & 

  2. Department of Biochemistry, University of Georgia, Athens, GA, USA

    J. Travis

  3. Postgraduate School of Respiratory Diseases, University of Pavia, Italy

    L. Casali

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer-Verlag London

About this chapter

Cite this chapter

Grassi, C., Luisetti, M. (1992). Pulmonary Emphysema: What’s Going On. In: Grassi, C., Travis, J., Casali, L., Luisetti, M. (eds) Biochemistry of Pulmonary Emphysema. Current Topics in Rehabilitation. Springer, London. https://doi.org/10.1007/978-1-4471-3771-9_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-3771-9_1

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-3773-3

  • Online ISBN: 978-1-4471-3771-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation